PRESS RELEASE published on 05/08/2024 at 08:30, 2 years 1 month ago Abivax announces presentation of four abstracts for obefazimod in ulcerative colitis and preclinical colon cancer model at Digestive Disease Week 2024 Abivax announces presentation of four abstracts for obefazimod in ulcerative colitis and preclinical colon cancer model at Digestive Disease Week 2024. The event will showcase new data on obefazimod's impact and mechanism of action Abivax Obefazimod Ulcerative Colitis Colon Cancer Digestive Disease Week 2024
BRIEF published on 05/07/2024 at 22:05, 2 years 1 month ago Abivax Announces Availability of Documents for Upcoming General Meeting Biotechnology Shareholder Information Corporate Governance Abivax General Meeting
BRIEF published on 05/07/2024 at 22:05, 2 years 1 month ago Abivax annonce la mise à disposition des documents pour la prochaine assemblée générale Biotechnologie Abivax Assemblée Générale Gouvernance D'Entreprise Informations Pour Les Actionnaires
PRESS RELEASE published on 05/07/2024 at 22:01, 2 years 1 month ago Abivax assemblée générale ordinaire annuelle et extraordinaire du 30 mai 2024 - Mise à disposition des documents préparatoires Abivax annonce la tenue de son assemblée générale annuelle et extraordinaire le 30 mai 2024 à Paris. Mise à disposition des documents préparatoires pour les actionnaires Biotechnologie Abivax Obefazimod Assemblée Générale Documents Préparatoires
PRESS RELEASE published on 05/07/2024 at 22:00, 2 years 1 month ago Abivax annual ordinary and extraordinary general meeting of May 30, 2024 - Availability of the preparatory documents Abivax informs shareholders of its ordinary and extraordinary general meeting on May 30, 2024, providing access to preparatory documents and details on participation. Obefazimod and Abivax information included Abivax Obefazimod General Meeting Clinical-stage Biotechnology Preparatory Documents
PRESS RELEASE published on 05/07/2024 at 22:00, 2 years 1 month ago Abivax annual ordinary and extraordinary general meeting of May 30, 2024 - Availability of the preparatory documents Abivax announces its annual ordinary and extraordinary general meeting on May 30, 2024, with preparatory documents available for shareholders. The meeting details, including agenda and resolutions, are accessible on the company's website Shareholders Biotechnology Abivax General Meeting Preparatory Documents
PRESS RELEASE published on 05/07/2024 at 22:00, 2 years 1 month ago Abivax assemblée générale ordinaire annuelle et extraordinaire du 30 mai 2024 - Mise à disposition des documents préparatoires Abivax annonce son assemblée générale annuelle et extraordinaire du 30 mai 2024 avec la mise à disposition des documents préparatoires. L'événement se tiendra à Paris Biotechnologie Abivax Assemblée Générale Traitements Thérapeutiques Documents Préparatoires
BRIEF published on 04/30/2024 at 18:05, 2 years 1 month ago ABIVAX rapporte le nombre d'actions et de droits de vote au 31 mars 2024 Autorité Des Marchés Financiers Droits De Vote Capital Social Abivax Informations Réglementaires
BRIEF published on 04/30/2024 at 18:05, 2 years 1 month ago ABIVAX reports the number of shares and voting rights as of March 31, 2024 Share Capital Voting Rights Financial Markets Authority Abivax Regulatory Information
PRESS RELEASE published on 04/30/2024 at 18:00, 2 years 1 month ago ABIVAX: Nombre d’actions composant le capital social et nombre total de droits de vote au 31.03.24. ABIVAX communique le nombre d'actions et de droits de vote au 31.03.24, conformément aux dispositions réglementaires. Abivax est une société de biotechnologie axée sur le développement de traitements thérapeutiques Droits De Vote Capital Social Biotechnologie Abivax Traitements Thérapeutiques
Published on 06/22/2026 at 13:00, 51 minutes ago NOA Lithium Signs Term Sheet for Option and Joint Venture with Summit Explore for Arizaro Project
Published on 06/22/2026 at 13:00, 51 minutes ago CoTec Holdings Corp. Notes HyProMag USA Advancement of Texas Hub and U.S. Magnet Platform
Published on 06/22/2026 at 13:00, 51 minutes ago Leggett Dynamics Launches Mid-Class Massage System & Makes Luxury Comfort Accessible on High-Volume Programs
Published on 06/22/2026 at 12:00, 1 hour 51 minutes ago CTT Pharma Signs LOI for Clinical Trials and Testing of Nicotine Products
Published on 06/22/2026 at 11:00, 2 hours 51 minutes ago American Critical Minerals Mobilizes to the Green River Project to Commence Drill Pad Construction
Published on 06/22/2026 at 13:40, 10 minutes ago Aroundtown SA: Release of a capital market information
Published on 06/22/2026 at 13:32, 18 minutes ago EQS-Adhoc: Aumann increases price of share buyback offer to €17.80 per share
Published on 06/22/2026 at 12:36, 1 hour 14 minutes ago Vienna Stock Exchange Admits SMRX Share of Emerald Horizon AG to Trading
Published on 06/22/2026 at 12:15, 1 hour 36 minutes ago OLB exercises previously announced right to call AT-1 bond
Published on 06/22/2026 at 12:05, 1 hour 45 minutes ago Geely Farizon, WeRide and Kwoon Chung Launch Right-Hand-Drive Robotaxis at 2026 International Automotive & Supply Chain Expo (Hong Kong), Accelerating Global Expansion
Published on 06/22/2026 at 08:30, 5 hours 21 minutes ago Eiffage entre en négociation exclusive avec Atlas Arteria en vue d’acquérir la concession du tunnel de Warnow à Rostock, en Allemagne
Published on 06/22/2026 at 08:30, 5 hours 21 minutes ago Eiffage enters into exclusive negotiations with Atlas Arteria for the possible acquisition of the Warnow Tunnel concession in Rostock, Germany
Published on 06/19/2026 at 19:33, 2 days 18 hours ago Déclaration hebdomadaire d'opérations effectuées du 15 au 19 juin 2026
Published on 06/19/2026 at 19:33, 2 days 18 hours ago Disclosure of transactions in own shares from June 15 to June 19, 2026
Published on 06/19/2026 at 19:23, 2 days 18 hours ago Imerys-06-2026-communique-capital-droits-de-vote-au-31-mai-2026